FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2597164018> ?p ?o ?g. }

• W2597164018 endingPage "34397" @default.
• W2597164018 startingPage "34387" @default.
• W2597164018 abstract "Transforming growth factor beta (TGF-β) promotes the pathogenesis of hepatocellular carcinoma (HCC). We evaluated the associations between TGF-β1 expression and clinicopathological parameters in HCC patients from The Cancer Genome Atlas (TCGA), as well as the prognostic power of TGF-β1 expression. Eligible studies were retrieved from several databases, and effects (hazard ratios (HRs) with 95% confidence intervals (CIs)) for overall survival (OS), disease-free survival (DFS), recurrence-free survival (RFS), metastasis-free survival (MFS), and progression-free survival (PFS) were pooled to assess the prognostic ability of TGF-β1 expression in HCC patients. Twelve qualified articles and our TCGA data comprising 2,021 HCC patients were incorporated. In the TCGA analysis, HCC patients with higher TGF-β1 expression presented a shorter OS than those with lower TGF-β1 expression (HR = 1.42, p < 0.05). In the meta-analysis, univariate analyses showed that HCC patients with higher TGF-β1 expression had a shorter OS (pooling HR = 1.71, p < 0.01) and DFS/RFS/MFS/PFS (pooling HR = 1.60, p < 0.01) than those with lower TGF-β1 expression. In conclusion, our results suggested that high TGF-β1 expression promotes a poor prognosis in HCC patients." @default.
• W2597164018 created "2017-03-23" @default.
• W2597164018 creator A5000801878 @default.
• W2597164018 creator A5001989498 @default.
• W2597164018 creator A5002028745 @default.
• W2597164018 creator A5024385167 @default.
• W2597164018 creator A5031438011 @default.
• W2597164018 creator A5039967620 @default.
• W2597164018 creator A5055108690 @default.
• W2597164018 creator A5073580810 @default.
• W2597164018 creator A5084555036 @default.
• W2597164018 creator A5091040124 @default.
• W2597164018 date "2017-03-13" @default.
• W2597164018 modified "2023-10-15" @default.
• W2597164018 title "High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients" @default.
• W2597164018 cites W1498499299 @default.
• W2597164018 cites W1530007295 @default.
• W2597164018 cites W1565561072 @default.
• W2597164018 cites W1757407923 @default.
• W2597164018 cites W1966832145 @default.
• W2597164018 cites W1967913719 @default.
• W2597164018 cites W1975173125 @default.
• W2597164018 cites W1996581577 @default.
• W2597164018 cites W1997558718 @default.
• W2597164018 cites W2008973552 @default.
• W2597164018 cites W2028850312 @default.
• W2597164018 cites W2030647318 @default.
• W2597164018 cites W2037535775 @default.
• W2597164018 cites W2046382781 @default.
• W2597164018 cites W2073473087 @default.
• W2597164018 cites W2075642745 @default.
• W2597164018 cites W2086648858 @default.
• W2597164018 cites W2088095316 @default.
• W2597164018 cites W2098585520 @default.
• W2597164018 cites W2099954091 @default.
• W2597164018 cites W2104072969 @default.
• W2597164018 cites W2107144403 @default.
• W2597164018 cites W2112657305 @default.
• W2597164018 cites W2116502112 @default.
• W2597164018 cites W2123065898 @default.
• W2597164018 cites W2151613224 @default.
• W2597164018 cites W2165426709 @default.
• W2597164018 cites W2167796946 @default.
• W2597164018 cites W2224685034 @default.
• W2597164018 cites W2276540943 @default.
• W2597164018 cites W2280923709 @default.
• W2597164018 cites W2281365274 @default.
• W2597164018 cites W2288728207 @default.
• W2597164018 cites W2290119977 @default.
• W2597164018 cites W2306717712 @default.
• W2597164018 cites W2316535371 @default.
• W2597164018 cites W2324292061 @default.
• W2597164018 cites W2346560849 @default.
• W2597164018 cites W2415755627 @default.
• W2597164018 cites W2512449392 @default.
• W2597164018 cites W2517114205 @default.
• W2597164018 cites W2528395192 @default.
• W2597164018 cites W2557193030 @default.
• W2597164018 cites W2558534037 @default.
• W2597164018 cites W4211233744 @default.
• W2597164018 cites W4242451313 @default.
• W2597164018 doi "https://doi.org/10.18632/oncotarget.16166" @default.
• W2597164018 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5470976" @default.
• W2597164018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28415739" @default.
• W2597164018 hasPublicationYear "2017" @default.
• W2597164018 type Work @default.
• W2597164018 sameAs 2597164018 @default.
• W2597164018 citedByCount "32" @default.
• W2597164018 countsByYear W25971640182017 @default.
• W2597164018 countsByYear W25971640182018 @default.
• W2597164018 countsByYear W25971640182019 @default.
• W2597164018 countsByYear W25971640182020 @default.
• W2597164018 countsByYear W25971640182021 @default.
• W2597164018 countsByYear W25971640182022 @default.
• W2597164018 countsByYear W25971640182023 @default.
• W2597164018 crossrefType "journal-article" @default.
• W2597164018 hasAuthorship W2597164018A5000801878 @default.
• W2597164018 hasAuthorship W2597164018A5001989498 @default.
• W2597164018 hasAuthorship W2597164018A5002028745 @default.
• W2597164018 hasAuthorship W2597164018A5024385167 @default.
• W2597164018 hasAuthorship W2597164018A5031438011 @default.
• W2597164018 hasAuthorship W2597164018A5039967620 @default.
• W2597164018 hasAuthorship W2597164018A5055108690 @default.
• W2597164018 hasAuthorship W2597164018A5073580810 @default.
• W2597164018 hasAuthorship W2597164018A5084555036 @default.
• W2597164018 hasAuthorship W2597164018A5091040124 @default.
• W2597164018 hasBestOaLocation W25971640181 @default.
• W2597164018 hasConcept C118131993 @default.
• W2597164018 hasConcept C121608353 @default.
• W2597164018 hasConcept C126322002 @default.
• W2597164018 hasConcept C143998085 @default.
• W2597164018 hasConcept C144301174 @default.
• W2597164018 hasConcept C207103383 @default.
• W2597164018 hasConcept C2778019345 @default.
• W2597164018 hasConcept C2779013556 @default.
• W2597164018 hasConcept C38180746 @default.
• W2597164018 hasConcept C44249647 @default.
• W2597164018 hasConcept C50382708 @default.

• next